Hart; Barry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hart; Barry.The latest application filed is for "novel mek inhibitors for treating cardiomyopathies and related conditions".

Company Profile

0.5.16

Hart; Barry - Monticello MN
Hart; Barry - Palo Alto CA
Hart; Barry - Mountain View CA
Hart; Barry - Woodbridge CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Drug compounding skid and compounding method Grant 9,314,404 - Gonzalez-Miranda , et al. April 19, 2	2016-04-19
Novel Mek Inhibitors For Treating Cardiomyopathies And Related Conditions App 20150250762 - Worman; Howard J. ; et al.	2015-09-10
Drug Compounding Skid And Compounding Method App 20140209727 - Gonzalez-Miranda; Jose ; et al.	2014-07-31
Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof Grant 8,324,417 - Hart , et al. December 4, 2	2012-12-04
Process For The Preparation Of (s)-2-amino-5-cyclopropyl-4,4-difluoropentanoic Acid And Alkyl Esters And Acid Salts Thereof App 20110046406 - Hart; Barry ; et al.	2011-02-24
Rho-kinase Inhibitors App 20100216789 - NAGARATHNAM; Dhanapalan ; et al.	2010-08-26
Rho-kinase Inhibitors App 20100137324 - Nagarathnam; Dhanaphalan ; et al.	2010-06-03
Process For Preparing Quinazoline Rho-kinase Inhibitors And Intermediates Thereof App 20100125139 - BANKSTON; Donald ; et al.	2010-05-20
Substituted thieno[3,2-D]pyrimidines as Rho kinase inhibitors Grant 7,648,986 - Nagarathnam , et al. January 19, 2	2010-01-19
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof Grant 7,645,878 - Bankston , et al. January 12, 2	2010-01-12
Rho-kinase Inhibitors App 20070238741 - Nagarathnam; Dhanapalan ; et al.	2007-10-11
Fused bicyclic inhibitors of TGFbeta App 20070066632 - Hart; Barry ; et al.	2007-03-22
Carboxamide inhibitors of TGFbeta App 20060281763 - Axon; Jonathan R. ; et al.	2006-12-14
Rho-kinase inhibitors App 20060142313 - Nagarathnam; Dhanaphalan ; et al.	2006-06-29
4-amino-5,6-substituted Thiopheno [2,3-d] Pyrimidines, Pharmaceutical Compositions Containing The Same, And Their Use In The Treatment Or Prevention Of Pde7b-mediated Diseases And Conditions Grant 6,849,638 - Stolle , et al. February 1, 2	2005-02-01
Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitors App 20040209924 - Hart, Barry ; et al.	2004-10-21
Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitors App 20040198773 - Hart, Barry ; et al.	2004-10-07
Rho-kinase inhibitors App 20040014755 - Nagarathnam, Dhanapalan ; et al.	2004-01-22
Process for preparing quinazoline Rho-kinase inhibitiors and intermediates thereof App 20030220357 - Bankston, Donald ; et al.	2003-11-27
Rho-kinase inhibitors App 20030125344 - Nagarathnam, Dhanaphalan ; et al.	2003-07-03
4-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of PDE7B-mediated diseases and conditions App 20030119829 - Stolle, Andreas ; et al.	2003-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.